Close Menu
  • Home
  • Finance News
  • Personal Finance
  • Investing
  • Cards
    • Credit Cards
    • Debit
  • Insurance
  • Loans
  • Mortgage
  • More
    • Save Money
    • Banking
    • Taxes
    • Crime
What's Hot

Mutual of Omaha Mortgage Review: They Lead with Low Rates, But Check the Closing Costs

November 4, 2025

UBER SRPT PLTR NCLH and more

November 4, 2025

Global Payments earnings beat Wall Street estimates | PaymentsSource

November 4, 2025
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram
Smart SpendingSmart Spending
Subscribe
  • Home
  • Finance News
  • Personal Finance
  • Investing
  • Cards
    • Credit Cards
    • Debit
  • Insurance
  • Loans
  • Mortgage
  • More
    • Save Money
    • Banking
    • Taxes
    • Crime
Smart SpendingSmart Spending
Home»Finance News»PLTR, HIMS, VRTX and more
Finance News

PLTR, HIMS, VRTX and more

August 5, 2025No Comments2 Mins Read
Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
PLTR, HIMS, VRTX and more
Share
Facebook Twitter LinkedIn Pinterest Email

Check out the companies making headlines in extended trading: Palantir — The defense technology stock advanced 4% after second-quarter earnings exceeded Wall Street’s expectations. Palantir said it reported adjusted earnings of 16 cents per share on $1 billion in revenue, while analysts polled by LSEG anticipated 14 cents in earnings per share and $940 million in revenue. Vertex Pharmaceuticals — The biotech stock sank 14% after second-quarter earnings topped estimates. Vertex posted adjusted earnings of $4.52 per share on revenue of $2.96 billion, while analysts surveyed by LSEG had penciled in $4.26 in earnings per share and $2.91 billion in revenue. Hims & Hers Health — Shares tumbled 12% after the telehealth company issued disappointing guidance. Hims sees third-quarter adjusted earnings before interest, taxes, depreciation and amortization ranging from $60 million to $70 million, while StreetAccount consensus estimates called for $77 million. Second-quarter results were mixed, with revenue missing expectations, while adjusted earnings narrowly beat. Syndax Pharmaceuticals — The biopharma stock slipped 3% after Syndax guided for a third-quarter research and development expense of between $95 million and $100 million, while analysts polled by FactSet had expected $65.8 million. However, the company posted second-quarter revenue that exceeded expectations, as well as a narrower-than-expected loss per share. Dorman Products — The vehicle parts supplier popped 7% after hiking its full-year earnings guidance to between $8.60 and $8.90 per share, excluding items, from a range of $7.55 to $7.85 a share. Dorman also issued better-than-expected top- and bottom-line results for the second quarter, per FactSet. V2X — Shares rose more than 2% after the aerospace and defense company’s second-quarter results beat Wall Street’s expectations. V2X posted adjusted earnings of 33 cents per share, while analysts polled by FactSet had penciled in 97 cents per share. The company’s revenue of $1.08 billion also beat the consensus estimate of $1.05 billion. Additionally, it raised its full-year earnings forecast. MercadoLibre — Shares dropped 4% after the Latin American e-commerce platform reported second-quarter earnings that missed expectations. MercadoLibre posted earnings of $10.31 per share, below the $11.93 per share estimated by analysts polled by FactSet. On the other hand, expected revenue of $6.79 billion topped the $6.67 billion consensus estimate. — CNBC’s Darla Mercado, Sean Conlon, Lisa Kailai Han and Sarah Min contributed reporting.

See also  UBER SRPT PLTR NCLH and more

Source link

HIMS PLTR VRTX
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
Previous ArticleFintech investment holds steady amid trade war
Next Article Top Mortgage Lenders in Nevada

Related Posts

UBER SRPT PLTR NCLH and more

November 4, 2025

Gen X is facing a retirement crisis, reports show

November 4, 2025

Fed Governor Lisa Cook, in first policy speech since Trump suit, says she’s undecided on Dec. rate cut

November 4, 2025
Add A Comment
Leave A Reply Cancel Reply

Top Posts

Here’s How The Saver’s Credit Can Lower Your Tax Bill by $2,000

December 27, 2024

Do I have enough money to retire? 3 questions to ask yourself

October 25, 2024

Student Loan Recertification Extensions Announced For Borrowers

March 21, 2025
Ads Banner

Subscribe to Updates

Subscribe to Get the Latest Financial Tips and Insights Delivered to Your Inbox!

Stay informed with our finance blog! Get expert insights, money management tips, investment strategies, and the latest financial news to help you make smart financial decisions.

We're social. Connect with us:

Facebook X (Twitter) Instagram YouTube
Top Insights

Mutual of Omaha Mortgage Review: They Lead with Low Rates, But Check the Closing Costs

November 4, 2025

UBER SRPT PLTR NCLH and more

November 4, 2025

Global Payments earnings beat Wall Street estimates | PaymentsSource

November 4, 2025
Get Informed

Subscribe to Updates

Subscribe to Get the Latest Financial Tips and Insights Delivered to Your Inbox!

© 2025 Smartspending.ai - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.